STALEVO tablets, which contain carbidopa, levodopa, and entacapone, are indicated for certain patients with Parkinson's disease.
If you are on levodopa therapy (carbidopa/levodopa) and experiencing symptom
reemergence due to "wearing-off," it may be time to ask about STALEVO. (NOTE: This is only for patients taking less than 600 mg of levodopa daily and not experiencing dyskinesias.)
If you are taking levodopa therapy and COMTAN® (entacapone) 200 mg tablets, you might be able to switch to STALEVO, a single tablet that contains all three medicines: carbidopa, levodopa, and entacapone.
|
| |
| |
| STALEVO does more than carbidopa/levodopa alone. It has been clinically proven to deliver more active time during the day—an average of almost an hour and a half each day (1.4 hours). So you can enjoy more time with fewer symptoms. |
| |
| |
People who take STALEVO may have more active time between doses, which may improve their daily activities.
|
|
|
